Evidence map›Paper›PMID 39377264›Full record

ArticleAging cell2025

Increased levels of extracellular matrix proteins associated with extracellular vesicles from brains of aged mice.

Azariah K Kaplelach, Charles F Murchison, Kyoko Kojima, James A Mobley, Andrew E Arrant

Abstract read
In one paragraph

Article in Aging cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Azariah K KaplelachCenter for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Charles F MurchisonCenter for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kyoko KojimaInstitutional Research Core Program/Mass Spectrometry, University of Alabama at Birmingham, Birmingham, Alabama, USA.
James A MobleyInstitutional Research Core Program/Mass Spectrometry, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Andrew E ArrantCenter for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0003-4706-9411

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Omer Jamy · 1985 to 2026
$165.9M
UAB Alzheimer's Disease Research CenterP30AG086401 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Marissa C Natelson Love · 2024 to 2026
$17.1M
UAB Alzheimer's Disease Research CenterP20AG068024 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GELDMACHER, DAVID S · 2020 to 2022
$3.3M
Abnormal Late Endosomal Trafficking in Frontotemporal Dementia due to Progranulin MutationR00AG056597 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ARRANT, ANDREW EMMETT · 2019 to 2021
$747k
NCI NIH HHS P30 CA013148NCI NIH HHS P30CA013148NIA NIH HHS P20 AG068024NIA NIH HHS P20AG068024NIA NIH HHS P30 AG086401NIA NIH HHS P30AG086401NIA NIH HHS R00 AG056597NIA NIH HHS R00AG056597
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are secreted by all major cell types of the brain, providing a mode of intercellular communication and a pathway for disposal of cellular debris. EVs help maintain healthy brain function, but may also contribute to diseases affecting the brain. EVs might contribute to aging of the brain, as aging-related processes such as inflammation and cellular senescence may alter EV cargo, promoting further inflammation and senescence. However, the effects of aging on brain EVs and the function of EVs in the aging brain remain poorly understood. To address this question, we measured the levels and protein cargo of EVs isolated from the brains of 4-, 12-, and 22-month-old C57BL/6J mice. We detected no changes in EV levels, but observed age-dependent changes in EV proteins. EV fractions from aged (22 month old) brains contained higher levels of extracellular matrix proteins than EV fractions from young (4 month old) brains, with intermediate levels in 12-month-old brains. Specifically, EV fractions from aged mice contained elevated levels of hyaluronan and proteoglycan link proteins 1 and 2 and several chondroitin sulfate proteoglycans (CSPGs). Analysis of extracellular matrix in several brain regions of aged mice revealed increased immunolabeling for the CSPG aggrecan, but reduced labeling with Wisteria floribunda agglutinin, which binds to chondroitin sulfate side chains of CSPGs. These data are consistent with prior studies showing changes to the composition of extracellular matrix in aged brains, and indicate a novel association of EVs with changes in the extracellular matrix of the aging brain.

Indexed as

AgingBrainExtracellular Matrix ProteinsExtracellular VesiclesMice, Inbred C57BLAnimalsExtracellular MatrixMaleMiceExtracellular Matrix Proteinsagingextracellular matrixextracellular vesicles

Identifiers

PMID39377264
PMCPMC11709096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.